News und Analysen
EQS-News: Australia's largest telecommunications company equips first transmission masts with self-sufficient hydrogen system from H2 Core AG
EQS-News: Weng Fine Art AG: ARTNET STAKE SOLD FOR € 15.2 MILLION
EQS-News: tick Trading Software AG reorganizes sales and customer management
Mitsui Chemicals lanciert neuen Corporate Venture Capital Fund „321Catalyst™“
Mitsui Chemicals, Inc. (Tokio: 4183; Präsident und CEO: Osamu Hashimoto), ein globaler Chemiehersteller mit Sitz in Japan, gab heute die Gründung seines zweiten Corporate Venture Capital Fund
From Albania to Burundi...a day for little heroes: Fix&Foxi TV & SOS Children's Villages worldwide celebrate International Children's Day
EQS-News: Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma
Transaction in Own Shares
EQS-News: InTiCa Systems SE: Annual report for 2024 published – Provisional figures confirmed
EQS-News: Beowolff Capital Announces to Launch Voluntary Public Takeover and Delisting Offer for artnet AG
EQS-Adhoc: artnet AG: SCUR-Alpha 1849 GmbH (in future: Leonardo Art Holdings GmbH) announces takeover and delisting offer based on an investment and delisting agreement with artnet AG
Mitsui Chemicals Launches New Corporate Venture Capital Fund ‘321Catalyst™’
Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu), a global chemicals manufacturer based in Japan, today announced the launch of its second Corporate Venture Capital Fund
Form 8.3 - The Vanguard Group, Inc.: Urban Logistics REIT plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
EQS-News: IBU-tec advanced materials AG: Shareholders approve all agenda items with a large majority at the Annual General Meeting
EQS-News: Mountain Alliance AG publishes Annual Report 2024 – Net Asset Value per share at €6.17
EQS-News: Change in management and clear majorities at the 2025 Annual General Meeting of Ernst Russ AG
EQS-News: YOC AG PUBLISHES FINANCIAL REPORT FOR Q1/2025: REVENUE GROWTH DESPITE DECLINING MARKET MOMENTUM
Fuller, Smith & Turner PLC: Transaction in own shares
Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Northisle Announces Board Slate for 2025 AGM
Northisle Copper and Gold Inc. (TSX-V: NCX) (“Northisle” or the “Company”) is pleased to announce the slate of directors for its upcoming 2025 AGM. The Company has continued to add highly capable




